Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 18;16(6):891.
doi: 10.3390/ph16060891.

The Role of AI in Drug Discovery: Challenges, Opportunities, and Strategies

Affiliations
Review

The Role of AI in Drug Discovery: Challenges, Opportunities, and Strategies

Alexandre Blanco-González et al. Pharmaceuticals (Basel). .

Abstract

Artificial intelligence (AI) has the potential to revolutionize the drug discovery process, offering improved efficiency, accuracy, and speed. However, the successful application of AI is dependent on the availability of high-quality data, the addressing of ethical concerns, and the recognition of the limitations of AI-based approaches. In this article, the benefits, challenges, and drawbacks of AI in this field are reviewed, and possible strategies and approaches for overcoming the present obstacles are proposed. The use of data augmentation, explainable AI, and the integration of AI with traditional experimental methods, as well as the potential advantages of AI in pharmaceutical research, are also discussed. Overall, this review highlights the potential of AI in drug discovery and provides insights into the challenges and opportunities for realizing its potential in this field. Note from the human authors: This article was created to test the ability of ChatGPT, a chatbot based on the GPT-3.5 language model, in terms of assisting human authors in writing review articles. The text generated by the AI following our instructions (see Supporting Information) was used as a starting point, and its ability to automatically generate content was evaluated. After conducting a thorough review, the human authors practically rewrote the manuscript, striving to maintain a balance between the original proposal and the scientific criteria. The advantages and limitations of using AI for this purpose are discussed in the last section.

Keywords: AI-assisted content generation; AI-limitations; artificial intelligence; drug discovery.

PubMed Disclaimer

Conflict of interest statement

Author Alexandre Blanco-González was employed by the company MD.USE Innovations SL. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Graphical flowchart illustrating the development process of a pharmacologically active molecule, from design to knowledge communication and transfer. AI-based approaches complement traditional methods but still cannot replace human expertise. By combining the predictive power of AI with human researchers’ knowledge, the drug discovery process can be optimized and accelerated. The present work examines the cutting-edge advancements in the stages of “Literature revision and analysis” and “Write scientific reports and publications” (highlighted in red) using ChatGPT, a chatbot based on the GPT-3.5 language model.

References

    1. OpenAI. ChatGPT (Dec 6 Version) [Large Language Model] 2022. [(accessed on 6 December 2022)]. Available online: https://chat.openai.com/chat.
    1. Plagiarism Detector Software|Anti-Plagiarism Tools|Copyleaks. [(accessed on 6 December 2022)]. Available online: https://copyleaks.com.
    1. Paul D., Sanap G., Shenoy S., Kalyane D., Kalia K., Tekade R.K. Artificial intelligence in drug discovery and development. Drug Discov. Today. 2021;26:80–93. doi: 10.1016/j.drudis.2020.10.010. - DOI - PMC - PubMed
    1. Xu Y., Liu X., Cao X., Huang C., Liu E., Qian S., Liu X., Wu Y., Dong F., Qiu C.W., et al. Artificial intelligence: A powerful paradigm for scientific research. Innovation. 2021;2:100179. doi: 10.1016/j.xinn.2021.100179. - DOI - PMC - PubMed
    1. Zhuang D., Ibrahim A.K. Deep learning for drug discovery: A study of identifying high efficacy drug compounds using a cascade transfer learning approach. Appl. Sci. 2021;11:7772. doi: 10.3390/app11177772. - DOI

LinkOut - more resources